ChemicalBook
English   Japanese   Germany   Korea

Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester

, 2096986-72-8, 结构式
CAS号:
2096986-72-8
英文名:
Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester
英文别名:
tert-Butyl 5-propionyl-1,5,6,7-tetrahydro-1''h-spiro[imidazo[4,5-c]pyridine-4,4''-piperidine]-1''-carboxylate;Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester
中文名:
中文别名:
CBNumber:
CB38299968
分子式:
C18H28N4O3
分子量:
348.44
MOL File:
2096986-72-8.mol

Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester化学性质

沸点:
581.1±50.0 °C(Predicted)
密度:
1.22±0.1 g/cm3(Predicted)
酸度系数(pKa):
14.72±0.20(Predicted)
安全信息

Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester性质、用途与生产工艺

Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester 上下游产品信息

上游原料

下游产品

Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester 生产厂家

全球有 2家供应商   Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester国内生产厂家
供应商联系电话电子邮件国家产品数优势度
杭州摩库生物医药科技有限公司 +86-057181025280; +8617767106207 sales@molcore.com 中国 49739 58
 

2096986-72-8, Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester 相关搜索:

  • 2096986-72-8
  • tert-Butyl 5-propionyl-1,5,6,7-tetrahydro-1''h-spiro[imidazo[4,5-c]pyridine-4,4''-piperidine]-1''-carboxylate
  • Spiro[4H-imidazo[4,5-c]pyridine-4,4'-piperidine]-1'-carboxylic acid, 3,5,6,7-tetrahydro-5-(1-oxopropyl)-, 1,1-dimethylethyl ester
Copyright 2016 © ChemicalBook. All rights reserved